Use of ARNI in HFpEF patients reduces NT-proBNP levels - PACE-CME

Use of ARNI in HFpEF patients reduces NTproBNP levels

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

One step closer to controlling LDL-c levels in HoFH with PCSK9i
One step closer to controlling LDL-c levels in HoFH with PCSK9i
ACC 2020
One step closer to controlling LDL-c levels in HoFH with PCSK9i
- Dirk Blom, PhD
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
ACC 2020
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
- Prof. George Dangas, MD, PhD
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
ACC 2020
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
- Prof. Freek Verheugt, MD
Higher rate of smoking cessation with e-cigarettes compared to counseling
Higher rate of smoking cessation with e-cigarettes compared to counseling
ACC 2020
Higher rate of smoking cessation with e-cigarettes compared to counseling
- Prof. Mark Eisenberg, MD